BLEE Fundamental Analysis - BLEECKER

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to BLEE. BLEE was compared to 42 industry peers in the Diversified REITs industry. Both the profitability and financial health of BLEE have multiple concerns. BLEE is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BLEE has reported negative net income.

In the past year BLEE had a positive cash flow from operations.

BLEE had negative earnings in 4 of the past 5 years.

Each year in the past 5 years BLEE had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -1.55%, BLEE is not doing good in the industry: 78.57% of the companies in the same industry are doing better.

Looking at the Return On Equity, with a value of -3.77%, BLEE is doing worse than 80.95% of the companies in the same industry.

The Return On Invested Capital of BLEE (0.92%) is worse than 83.33% of its industry peers.

BLEE had an Average Return On Invested Capital over the past 3 years of 1.20%. This is below the industry average of 3.45%.

		Industry Rank	Sector Rank
ROA	-1.55%
ROE	-3.77%
ROIC	0.92%

ROA(3y)-4.02%

ROA(5y)-0.44%

ROE(3y)-9.45%

ROE(5y)-1.9%

ROIC(3y)1.2%

ROIC(5y)0.87%

1.3 Margins

BLEE's Operating Margin of 28.66% is on the low side compared to the rest of the industry. BLEE is outperformed by 76.19% of its industry peers.

BLEE's Operating Margin has improved in the last couple of years.

BLEE has a worse Gross Margin (48.70%) than 73.81% of its industry peers.

In the last couple of years the Gross Margin of BLEE has grown nicely.

		Industry Rank	Sector Rank
OM	28.66%
PM (TTM)	N/A
GM	48.7%

OM growth 3Y50.6%

OM growth 5Y1.51%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y15.93%

GM growth 5Y6.49%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLEE is destroying value.

The number of shares outstanding for BLEE remains at a similar level compared to 1 year ago.

Compared to 5 years ago, BLEE has about the same amount of shares outstanding.

Compared to 1 year ago, BLEE has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.77, we must say that BLEE is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 0.77, BLEE perfoms like the industry average, outperforming 42.86% of the companies in the same industry.

BLEE has a debt to FCF ratio of 50.91. This is a negative value and a sign of low solvency as BLEE would need 50.91 years to pay back of all of its debts.

BLEE has a worse Debt to FCF ratio (50.91) than 80.95% of its industry peers.

BLEE has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 1.22, BLEE is not doing good in the industry: 80.95% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	1.22
Debt/FCF	50.91
Altman-Z	0.77

ROIC/WACC0.2

WACC4.62%

2.3 Liquidity

A Current Ratio of 0.56 indicates that BLEE may have some problems paying its short term obligations.

BLEE has a better Current ratio (0.56) than 61.90% of its industry peers.

BLEE has a Quick Ratio of 0.56. This is a bad value and indicates that BLEE is not financially healthy enough and could expect problems in meeting its short term obligations.

BLEE's Quick ratio of 0.56 is fine compared to the rest of the industry. BLEE outperforms 64.29% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.56
Quick Ratio	0.56

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 77.23% over the past year.

The Revenue for BLEE has decreased by -18.19% in the past year. This is quite bad

The Revenue has been growing slightly by 1.50% on average over the past years.

EPS 1Y (TTM)77.23%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%67.77%

Revenue 1Y (TTM)-18.19%

Revenue growth 3Y0.82%

Revenue growth 5Y1.5%

Sales Q2Q%-15.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLEE. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, BLEE is valued a bit more expensive than the industry average as 73.81% of the companies are valued more cheaply.

		Industry Rank	Sector Rank
P/FCF	18.84
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for BLEE!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

BLEECKER

EPA:BLEE (1/8/2026, 7:00:00 PM)

108

+9.5 (+9.64%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)11-27 2025-11-27

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners71.74%

Ins Owner ChangeN/A

Market Cap122.04M

Revenue(TTM)24.51M

Net Income(TTM)-9.41M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	4.98
P/FCF	18.84
P/OCF	8.56
P/B	0.49
P/tB	0.49
EV/EBITDA	N/A

EPS(TTM)-8.37

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)5.73

FCFY5.31%

OCF(TTM)12.62

OCFY11.69%

SpS21.69

BVpS221.1

TBVpS218.45

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.55%
ROE	-3.77%
ROCE	1.25%
ROIC	0.92%
ROICexc	0.92%
ROICexgc	0.92%
OM	28.66%
PM (TTM)	N/A
GM	48.7%
FCFM	26.43%

ROA(3y)-4.02%

ROA(5y)-0.44%

ROE(3y)-9.45%

ROE(5y)-1.9%

ROIC(3y)1.2%

ROIC(5y)0.87%

ROICexc(3y)1.21%

ROICexc(5y)0.87%

ROICexgc(3y)1.22%

ROICexgc(5y)0.88%

ROCE(3y)1.64%

ROCE(5y)1.18%

ROICexgc growth 3Y51.04%

ROICexgc growth 5Y4.77%

ROICexc growth 3Y51.05%

ROICexc growth 5Y4.77%

OM growth 3Y50.6%

OM growth 5Y1.51%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y15.93%

GM growth 5Y6.49%

F-Score5

Asset Turnover0.04

Health

		Industry Rank	Sector Rank
Debt/Equity	1.22
Debt/FCF	50.91
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	31.77%
Interest Coverage	0.48
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.56
Quick Ratio	0.56
Altman-Z	0.77

F-Score5

WACC4.62%

ROIC/WACC0.2

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)19.59%

Cap/Sales(5y)39.21%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)77.23%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%67.77%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-18.19%

Revenue growth 3Y0.82%

Revenue growth 5Y1.5%

Sales Q2Q%-15.48%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-38.45%

EBIT growth 3Y51.83%

EBIT growth 5Y3.03%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y884.35%

FCF growth 3YN/A

FCF growth 5Y6.31%

OCF growth 1Y76.82%

OCF growth 3Y279.98%

OCF growth 5Y9.63%

BLEECKER / BLEE.PA FAQ

What is the ChartMill fundamental rating of BLEECKER (BLEE.PA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to BLEE.PA.

What is the valuation status for BLEE stock?

ChartMill assigns a valuation rating of 0 / 10 to BLEECKER (BLEE.PA). This can be considered as Overvalued.

Can you provide the profitability details for BLEECKER?

BLEECKER (BLEE.PA) has a profitability rating of 2 / 10.

Is the dividend of BLEECKER sustainable?

The dividend rating of BLEECKER (BLEE.PA) is 0 / 10 and the dividend payout ratio is 0%.

BLEECKER (BLEE.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BLEECKER / BLEE.PA FAQ

What is the ChartMill fundamental rating of BLEECKER (BLEE.PA) stock?

What is the valuation status for BLEE stock?

Can you provide the profitability details for BLEECKER?

Is the dividend of BLEECKER sustainable?